Microbial-encoded metabolic pathways—specifically those involved in the urea cycle, polyamine synthesis, and metabolism of methionine and cysteine—correlated with worse cognitive performance in older adults at risk for Alzheimer's disease.
Key Findings
Methods
Gut microbiome functional gene pathways were associated with cognitive performance in older adults along the Alzheimer's disease continuum.
A cohort of 260 older adults aged 60 years or older living in the community was recruited and followed over time.
Subjects were classified as healthy controls, exhibiting mild cognitive impairment, or having dementia based on clinical assessments.
Metagenomic sequencing and gene pathway analyses were used to identify associations between microbial metabolic pathways and cognition.
Objective measures of cognition, clinical information, and gut microbiome samples were tracked over time.
Results
Microbial genes involved in the urea cycle predicted worse cognitive performance.
Urea cycle-related microbial gene pathways were among those specifically identified as correlating with worse cognitive outcomes.
This finding was identified through metagenomic sequencing and gene pathway analyses.
The association was observed across the AD continuum including healthy controls, MCI, and dementia groups.
Results
Microbial genes involved in polyamine synthesis were associated with worse cognitive performance.
Polyamine synthesis pathways encoded by gut microbiota were identified as correlating with worse cognitive performance.
Polyamine metabolism is a recognized pathway with potential systemic and neuroinflammatory implications.
This was identified alongside urea cycle and methionine/cysteine pathways as a key finding of the study.
Results
Microbial genes involved in methionine and cysteine metabolism predicted worse cognitive performance.
Metabolism of methionine and cysteine by gut microbiota was specifically identified as correlating with worse cognitive outcomes.
These metabolic pathways were among those that 'predicted worse cognitive performance' according to the authors.
Methionine and cysteine metabolism intersects with known pathways relevant to neuroinflammation and systemic physiology.
Background
Changes in gut microbiome composition may offer clues to potential systemic physiologic and neuropathologic changes contributing to cognitive decline.
The study is consistent with multiple lines of emerging evidence supporting the microbiome's involvement in AD disease pathology.
The proposed mechanism involves triggering or potentiating systemic and neuroinflammation through the 'microbiota-gut-brain axis.'
The authors note that copathologies contributing to cognitive decline and symptomatic progression in AD 'remain unknown and understudied.'
Conclusions
The study suggests that gut microbiome composition may be linked to cognitive impairment along the AD continuum and points to microbial metabolic pathways that may potentiate disease.
The study followed participants over time, providing longitudinal data on cognitive measures and microbiome samples.
Three cognitive classification groups were examined: healthy controls, mild cognitive impairment, and dementia.
The authors conclude that identified microbial metabolic pathways 'may potentiate disease' rather than merely correlate with its presence.
What This Means
This research suggests that the community of microorganisms living in the gut—the gut microbiome—may play a role in cognitive decline associated with Alzheimer's disease. The researchers followed 260 older adults (age 60 and above) over time, collecting gut microbiome samples and measuring cognitive function. By analyzing the genetic material of the gut bacteria using advanced sequencing techniques, they were able to identify specific metabolic functions performed by these microbes that were linked to poorer cognitive performance. Specifically, three types of bacterial metabolic activity stood out: processes related to the urea cycle (which handles nitrogen waste), polyamine synthesis (production of molecules involved in cell growth), and the metabolism of the amino acids methionine and cysteine.
This research suggests that gut bacteria are not just passive residents of the digestive system but may actively influence brain health through chemical signals and metabolic products that affect inflammation throughout the body and potentially in the brain itself. The 'gut-brain axis'—a communication pathway between the digestive system and the brain—is thought to be one route by which these microbial activities could influence the progression of Alzheimer's-related cognitive decline. The fact that specific metabolic pathways, rather than just which bacteria are present, were linked to cognitive outcomes is notable because it points toward functional mechanisms rather than simple associations.
This research matters because it may eventually help identify people at greater risk for cognitive decline based on their gut microbiome profile, and could point toward new targets for intervention. If certain microbial metabolic activities are shown to worsen cognitive outcomes, future research might explore whether dietary changes, probiotics, or other approaches that shift these microbial functions could affect disease progression. However, the study identifies associations and potential mechanisms rather than proving causation, and more research is needed to confirm and build on these findings.
Zeamer A, Lai Y, Loew E, Sanborn V, Tracy M, Jo C, et al.. (2026). Microbiome functional gene pathways are indicative of cognitive performance in older adults at risk for Alzheimer's disease.. Gut microbes. https://doi.org/10.1080/19490976.2026.2676162